These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29376979)

  • 21. Synthetic cannabinoid overdose in a 20-year-old male US soldier.
    Berry-Cabán CS; Ee J; Ingram V; Berry CE; Kim EH
    Subst Abus; 2013; 34(1):70-2. PubMed ID: 23327506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Products containing synthetic cannabinoids and psychosis.
    Brakoulias V
    Aust N Z J Psychiatry; 2012 Mar; 46(3):281-2. PubMed ID: 22391292
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating 'Devil׳s Breath׳ intoxication: Use of rivastigmine in six patients with toxic psychoses due to non pharmaceutical scopolamine.
    Sandia S I; Ramírez V J; Piñero A J; Baptista T T
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):833-834. PubMed ID: 28601550
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance abuse and psychosis. The strange case of opioids.
    Maremmani AG; Rovai L; Rugani F; Bacciardi S; Dell'Osso L; Maremmani I
    Eur Rev Med Pharmacol Sci; 2014; 18(3):287-302. PubMed ID: 24563427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients.
    Wang G; Zhang Y; Zhang S; Chen H; Xu Z; Schottenfeld RS; Hao W; Chawarski MC
    J Subst Abuse Treat; 2016 Mar; 62():84-8. PubMed ID: 26733277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical variants of psychoses in patients using synthetic cannabinoids (Spice)].
    Vinnikova MA; Skryabin VY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):23-26. PubMed ID: 32929920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone in the treatment of steroid-induced psychosis.
    Kramer TM; Cottingham EM
    J Child Adolesc Psychopharmacol; 1999; 9(4):315-6. PubMed ID: 10630463
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthetic Cannabinoid Receptor Agonists: a heterogeneous class of novel psychoactive substance with emerging risk of psychosis.
    Whiting D
    Evid Based Ment Health; 2015 Nov; 18(4):110. PubMed ID: 26363038
    [No Abstract]   [Full Text] [Related]  

  • 30. The behavioral profile of spice and synthetic cannabinoids in humans.
    Müller HH; Kornhuber J; Sperling W
    Brain Res Bull; 2016 Sep; 126(Pt 1):3-7. PubMed ID: 26548494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient.
    Peglow S; Buchner J; Briscoe G
    Am J Addict; 2012; 21(3):287-8. PubMed ID: 22494236
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistent psychosis associated with salvia divinorum use.
    Przekop P; Lee T
    Am J Psychiatry; 2009 Jul; 166(7):832. PubMed ID: 19570943
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of ciprofloxacin-induced acute polymorphic psychosis with a distinct deficit in executive functions.
    Grimm O; Alm B; Für Seelische Z
    Psychosomatics; 2007; 48(3):269. PubMed ID: 17478598
    [No Abstract]   [Full Text] [Related]  

  • 35. New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report.
    Alhassan A; Prahad SR; Burk BG; Fargason RE; Birur B
    Psychopharmacol Bull; 2024 Mar; 54(1):33-39. PubMed ID: 38449474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Lannon MC; Friedman JH; Abbott BP
    Mov Disord; 2000 May; 15(3):579-81. PubMed ID: 10830427
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome in cycloserine-induced psychosis.
    Sawant NS; Kate NS; Bhatankar SS; Kulkarni PS
    Indian J Pharmacol; 2015; 47(3):328-9. PubMed ID: 26069374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report of a case of steroid-induced psychosis and inappropriate sexual behaviour in an adolescent.
    Demir T; Karacetin G; Dogangun B; Kocabasoglu N
    Pharmacopsychiatry; 2012 Mar; 45(2):77-9. PubMed ID: 22086740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine in treatment of bromocriptine-induced psychosis.
    Al-Semaan YM; Clay HA; Meltzer HY
    J Clin Psychopharmacol; 1997 Apr; 17(2):126-8. PubMed ID: 10950481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.